Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Erdheim-Chester Disease (Early Phase 1)
Graft Rejection (Phase 2)
Heart Diseases (Phase 2)
Histiocytosis, Sinus (Early Phase 1)
Leukemia (Early Phase 1)
Lymphoma (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 3)
Lymphoma, Non-Hodgkin (Early Phase 1)
Multiple Myeloma (Phase 2)
Myocarditis (Phase 2)
Neoplasms (Early Phase 1)
Neuroendocrine Tumors (Early Phase 1)
Thymoma (Early Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue